Patients with type 2 diabetes and gastroparesis exhibited distinct continuous glucose monitoring metrics compared to those without gastroparesis.
Does Continuous Glucose Monitoring using FreeStyle Libre3 show distinct glucose metrics in patients with Type 2 Diabetes and Gastroparesis compared to those without Gastroparesis?
Patients with Type 2 Diabetes and gastroparesis exhibit altered continuous glucose monitoring metrics compared to those without gastroparesis, highlighting a need for targeted glycemic control strategies.
Absolute Event Rate: 0% vs 0%
Patients with T2D and GP showed distinct and altered CGM glucose metrics compared with those with T2D without GP. These findings highlight the need for better glycemic control in this population. Whether CGM metrics could help identify a specific biomarker for gastroparesis remains to be determined. Further validation with a broader population, including patients with T1D and GLP-1RAs, is necessary.
Garg et al. (Sun,) reported a other. Patients with type 2 diabetes and gastroparesis exhibited distinct continuous glucose monitoring metrics compared to those without gastroparesis.